Northern Trust’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.88M Buy
788,173
+194,780
+33% +$713K ﹤0.01% 2790
2025
Q1
$2.56M Sell
593,393
-22,696
-4% -$98K ﹤0.01% 2790
2024
Q4
$1.97M Buy
616,089
+17,196
+3% +$55K ﹤0.01% 3035
2024
Q3
$1.71M Buy
598,893
+9,898
+2% +$28.3K ﹤0.01% 3094
2024
Q2
$1.65M Sell
588,995
-27,594
-4% -$77.3K ﹤0.01% 3008
2024
Q1
$1.75M Sell
616,589
-9,318
-1% -$26.5K ﹤0.01% 3037
2023
Q4
$2.56M Buy
625,907
+3,271
+0.5% +$13.4K ﹤0.01% 2863
2023
Q3
$1.98M Buy
622,636
+21,526
+4% +$68.5K ﹤0.01% 2945
2023
Q2
$2M Sell
601,110
-96,192
-14% -$319K ﹤0.01% 3005
2023
Q1
$1.49M Sell
697,302
-43,261
-6% -$92.1K ﹤0.01% 3074
2022
Q4
$1.99M Buy
740,563
+53,182
+8% +$143K ﹤0.01% 2996
2022
Q3
$2.23M Buy
687,381
+13,259
+2% +$43K ﹤0.01% 2964
2022
Q2
$3.29M Buy
674,122
+766
+0.1% +$3.74K ﹤0.01% 2779
2022
Q1
$5.13M Buy
673,356
+201,487
+43% +$1.54M ﹤0.01% 2573
2021
Q4
$4.36M Buy
471,869
+2,621
+0.6% +$24.2K ﹤0.01% 2772
2021
Q3
$6.68M Sell
469,248
-13,288
-3% -$189K ﹤0.01% 2555
2021
Q2
$8.02M Buy
482,536
+151,586
+46% +$2.52M ﹤0.01% 2525
2021
Q1
$6.03M Sell
330,950
-1,646
-0.5% -$30K ﹤0.01% 2636
2020
Q4
$2.5M Buy
332,596
+63,304
+24% +$477K ﹤0.01% 3082
2020
Q3
$1.03M Sell
269,292
-9,852
-4% -$37.8K ﹤0.01% 3381
2020
Q2
$1.07M Buy
279,144
+73,533
+36% +$282K ﹤0.01% 3327
2020
Q1
$664K Buy
205,611
+52,249
+34% +$169K ﹤0.01% 3369
2019
Q4
$737K Buy
153,362
+37,238
+32% +$179K ﹤0.01% 3481
2019
Q3
$763K Buy
116,124
+75,058
+183% +$493K ﹤0.01% 3462
2019
Q2
$312K Buy
41,066
+23,540
+134% +$179K ﹤0.01% 3688
2019
Q1
$131K Buy
+17,526
New +$131K ﹤0.01% 3867